Síndroma de Trousseau e Adenocarcinoma do Coto Gástrico
Palavras-chave:
denocarcinoma do coto gástrico, síndromas paraneoplásicasResumo
Relata-se o caso clínico de um homem de 82 anos de
idade, com antecedentes de gastrectomia parcial por úlcera
gástrica, admitido no nosso hospital por trombose venosa
da popliteia direita. A investigação realizada conduziu ao
diagnóstico de adenocarcinoma (ADC) da boca anastomótica, já em fase de metastização hepática.
Acentua-se que os doentes gastrectomizados por doenças
benignas têm risco acrescido de ADC e que as síndromas
paraneoplásicas (nomeadamente sob a forma de trombose
venosa e/ou arterial ) podem ser uma manifestação inaugural destes tumores.
Downloads
Referências
Luukkonen P, Kalima T, Kivilaakso E. Decreased risk of gastric stump carcinoma after partial gastrectomy supplemented with bile diversion.
Hepatogastroenterology 1990; 37:390-394.
Ikeguchi M, Kondou A, Shibata S et al. Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial
gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach. Cancer 1994; 73:15-21.
Jotten J, Burns HJG, Kay AW. Time of onset of carcinoma of the stomach following surgical treatment of duodenal ulcer. Surg Gynecol Obstet
; 157:431-437.
Moreaux J, Mathey P, Msika S. Gastric adenocarcinoma in the gastric stump after partial gastrectomy. Hepatogastroenterology 1991; 38:
-521.
Ikeguchi M, Kondou A, Oka A, Tsujitani S, Maeta M, Kaibara N. Flow cytometric analysis of the DNA content of tumor cells in cases of gastric
cancer in the upper third of the stomach and in the remnant stomach. Oncology 1995; 52:116-122.
Lo SS, Wu CW, Hsieh MC, Lui WY. Is gastric remnant cancer clinically different from primary gastric cancer? Hepatogastroenterology 1997;
:299-301.
Stalnikowicz R and Benbasset J. Risk of Gastric Cancer after gastric surgery for benign disorders.Arch Int Med 1990; 150:2022-2026.
Kaminishi M, Shimizu N, Shiomoyama S et al. Etiology of gastric remnant cancer with special reference to the effects of denervation of
the gastric mucosa. Cancer 1995; 75 Suppl:1490-1496.
Yamamoto N, Tokunaga M, Uemura Y et al. Epstein-Barr virus and gastric remnant cancer. Cancer 1994; 74:805-809.
Safatle-Ribeiro AV, Ribeiro U Jr, Reynolds JC. Gastric stump cancer: what is the risk? Dig Dis 1998; 16:159-168.
Stael-von-Holstein C, Eriksson S, Huldt B, Hammar E. Endoscopic screening during 17 years for gastric stump carcinoma. A prospective
clinical trial. Scand J Gastroenterol 1991; 26:1020-1026.
Fujiwara T, Hirose S, Hamazaki K, Iwagaki H, Mano K, Orita K. Clinicopathological features of gastric cancer in the remnant stomach.
Hepatogastroenterology 1996; 43:416-419.
Greene FL. Management of gastric remnant carcinoma based on the results of a 15 year endoscopic screening program. Ann Surg 1996;
:701-708.
Luk GD. Chapter 44: Tumors of the Stomach in: Feldman M, Scharschmidt BF and Sleisenger, MH, eds. Gastrointestinal and liver disease.
Vol 1. 6th ed. Philadelphia. WB Saunders company; 1998; 733-757.
Prandoni P, Piccioli A, Girolami A. Cancer and venous thromboembolism: an overview. Haematologica 1999; 84:437-445.
Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;
:1846-1850.
Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res 2001; 102:V187-194
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
